AzTrials
AzTrials

Spinal Cord InjuriesNCT05954715

Ischaemic Preconditioning and Upper Body Exercise Performance in Persons With Spinal Cord Injury

A study testing Ischaemic Preconditioning in people with Spinal Cord Injuries, run by Loughborough University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Regular physical activity improves physical fitness, fatigue, quality of life, gait and reduces progression of the disability in persons with SCI. However, persons with SCI are less physically active than the general population. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Spinal Cord Injuries
What is being tested?
Ischaemic Preconditioning
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
40 participants
Where
No sites listed yet
Study dates
1 Nov 2023to 1 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age of 18 or older
  • Chronic spinal cord injury (>1 year post injury)

Who cannot join

  • ASIA Impairment scale E
  • Other co-morbidities- Traumatic brain injury, Brachial plexus injury, upper limb fractures, progressive neurological conditions (e.g., multiple sclerosis)
  • Patients known to have autonomic dysreflexia (AD) and having had an episode of AD in the last two weeks
  • Impaired triceps function (medical research council (MRC) power motor score of 3 out of 5, or lower)
  • Resting systolic BP of 170 mmHg or more
  • Inability to communicate in English

Trial locations and contacts

No sites are listed yet.

Sven Hoekstra, PhD contact

+447799115690

s.p.hoekstra@lboro.ac.uk

Rohit Bhide, MD contact

rohit.bhide@nhs.net

About this study

Official title: Does Ischaemic Preconditioning Improve Upper Body Exercise Performance in People With Spinal Cord Injury? A Feasibility Study

Regular physical activity improves physical fitness, fatigue, quality of life, gait and reduces progression of the disability in persons with SCI. However, persons with SCI are less physically active than the general population. Approximately 50% of people with SCI experience fatigue which impacts their daily activities.

Ischaemic preconditioning (IPC) is exposure of the body to brief periods of circulatory occlusion and reperfusion to protect organs against ischaemic injury. Recent studies have shown that IPC also improves exercise performance in healthy participants. The aim of this study is to determine whether it is feasible to use IPC to improve upper-body exercise performance in people with SCI.

Read more

Setting: Potential candidates will be identified from the Outpatient clinic at the Princess Royal Spinal Injuries Hospital (PRSCIC), Northern General Hospital, Sheffield.

Design: Acute single blind randomised controlled trial. Forty patients with SCI above 18 years and with preserved triceps function to conduct triceps strength testing will be randomised to receive either an IPC or sham intervention.

Interventions: IPC will be administered to the upper limb using cuff inflation pressures of 200 mmHg or 60mm Hg above the systolic BP (whichever is higher). Four cycles of cuff inflation each lasting 5 min in duration followed by 5-min period of cuff deflation will be applied. The Sham intervention will be administered with a BP cuff over the upper arm being inflated at a pressure 30mmg Hg below the diastolic blood pressure. The sham cycles will comprise of four cycles of cuff inflation each lasting 5 min in duration followed by 5-min period of cuff deflation.

Researchers will assess the feasibility of IPC as well as its efficacy to improve triceps maximal voluntary contraction and endurance compared with Sham.

Read the detailed description

Once participants have signed informed consent, they will undergo the following procedures:

  1. Randomisation into IPC vs Sham group B. Researcher will offer a suitable time to perform the study recording. C. Participant will be requested to spare up to 3 hours to complete the intervention.
  2. Intervention session (IPC / Sham):
  • Participant arrives.
  • On arrival, after 10 minutes of seated rest, baseline heart rate and blood pressure (BP) will be measured.
  • Two electrodes will be placed on the lateral triceps head for Electromyography (EMG) assessment during the triceps exercise capacity tests.
  • To determine maximum voluntary contraction (MVC), a warm-up of 2 contractions each of a participant-estimated 50% MVC, 70% MVC, and 90% MVC, will first be performed. Participants will then undertake up to 5 maximal isometric contractions of the triceps, from which the MVC value will be obtained (average of the best 3 contractions).
  • Following a rest period (5 minutes), a metronome will be used to give participants the cue to rhythmically isometrically contract their triceps (60 contraction-relaxation cycles/min) to a target value of 70% MVC.
  • The time to task failure and ability to complete the exercise will be noted.
  • Participants will report Rating of Perceived Exertion (RPE) using Borg's scale immediately after completing the exercise.
  • Before and after the exercise, a capillary blood sample will be obtained from the earlobe for assessment of blood lactate concentration. Heart rate will be measured throughout.
  • Repeat BP measurement.
  • 30 minutes rest.
  • Repeat BP and heart rate measurement.
  • The MVC will be determined again, followed by a 5-minute rest.
  • Proceed to intervention - 4 cycles of 5 minutes of IPC / Sham followed by 5 minutes of reperfusion. (Total 40 minutes).
  • IPC intervention - This will involve tying the cuff of a manual BP apparatus around the upper arm and inflated to a minimum of 200 mmHg, or a pressure of 60 mmHg above the resting systolic BP, whichever is higher. The inflation will be maintained for 5 min followed by cuff deflation lasting 5 min. The cycle will be repeated four times.
  • The Sham intervention will be delivered with the manual BP cuff tied to the upper arm. The cuff will be inflated 30 mm Hg below the diastolic BP for 5 min followed by deflation for 5 min. The cycle will be repeated four times.
  • 10 minutes rest.
  • Repeat pre-exercise capillary blood sample for determination of blood lactate concentration.
  • Repeat 5 maximal isometric contractions of the triceps.
  • Repeat a rest period of 5 min.
  • Repeat rhythmic isometric triceps contraction exercise. Again, time to task failure and ability to complete the exercise will be noted.
  • Repeat reading of Borg's Rating of Perceived Exertion (RPE) scale, post-exercise capillary blood sample, BP and heart rate measurements.
  • Recording of adverse events and numerical pain scale, open ended discussion around perceptions and tolerability of IPC.
  • 15 minutes rest.
  • Repeat BP and heart rate measurement.
  • Exit from study.
Being tested
Ischaemic Preconditioning, Sham
Keywords
Exercise capacity, Tolerability, Ischaemic preconditioning, Maximal voluntary contraction, Time to task failure, Fatigue
Medical subject headings
Spinal Cord Injuries, Fatigue

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ischaemic PreconditioningOther

    Four cycles of cuff inflation each lasting 5 min in duration followed by a 5-min period of cuff deflation will be applied.

  • ShamOther

    Four cycles of cuff inflation each lasting 5 min in duration followed by a 5-min period of cuff deflation will be applied.

Study groups in NCT05954715
Study groupRoleWhat they receive
IPC (Ischaemic Preconditioning)ExperimentalIPC will be administered to the upper limb using cuff inflation pressures of 200 mmHg or 60mm Hg above the systolic BP (whichever is higher). Four cycles of cuff inflation each lasting 5 min in duration followed by a 5-min period of cuff deflation will be applied.
Receives: Other: Ischaemic Preconditioning
ShamSham comparatorThe Sham intervention will be administered with a BP cuff over the upper arm being inflated at a pressure 30mmg Hg below the diastolic blood pressure. The sham cycles will comprise of four cycles of cuff inflation each lasting 5 min in duration followed by a 5-min period of cuff deflation.
Receives: Other: Sham

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intervention feasibility

    The intervention will be considered feasible if all of the below criteria are met:

    • 80% of the target sample is recruited within the first 9 months after the start of recruitment.
    • Of those who participate, 80% tolerate the ischemic preconditioning intervention, defined as ratings <7 using the numerical Pain Rating Scale that ranges from 0 to 10. Here 0 is considered no pain; 1 to 3 is mild pain; 4 to 6 is moderate pain and 7 to 10 is severe pain.
    • A full data set is obtained in 80% of the participants who start the intervention.

    Measured: Recruitment figures and tolerability will be collected throughout the 1 year study period.

Secondary outcomes (2)
  1. Maximal voluntary muscle contraction

    Maximal voluntary contraction of the triceps will be obtained before and after the intervention (IPC vs Sham).

    Measured: Maximal voluntary muscle contraction will be collected throughout the 1 year study period.

  2. Time to task failure during rhythmic muscle contraction

    Time to task failure during rhythmic triceps contraction will be obtained before and after the intervention (IPC vs Sham). The time that rhythmic triceps contractions at 70% of maximal voluntary contraction can be maintained will be recorded.

    Measured: Time to task failure during rhythmic muscle contraction will be collected throughout the 1 year study period.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jul 2023
  2. Study start1 Nov 2023 (estimated)
  3. Primary completion31 Dec 2024 (estimated)
  4. Study completion1 Jul 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Acute single blind randomised controlled trial
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05954715
Sponsor's protocol ID
STH22013
Status last verified
Jul 2023
First submitted
30 Jun 2023
Last updated
2 Aug 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Ischaemic Preconditioning in people with Spinal Cord Injuries, run by Loughborough University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Sven Hoekstra, PhD (+447799115690, s.p.hoekstra@lboro.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intervention feasibility (time frame: Recruitment figures and tolerability will be collected throughout the 1 year study period.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in